Nextage Therapeutics Ltd (TLV:NXTG)
Israel · Delayed Price · Currency is ILS · Price in ILA 38.70
+2.90 (8.10%)
Sep 2, 2026, 5:24 PM IDT
Nextage Therapeutics Market Cap
Nextage Therapeutics has a market cap or net worth of 13.04 million as of September 2, 2026. Its market cap has decreased by -60.55% in one year.
Market Cap
13.04M
Enterprise Value
20.17M
Revenue
2.51M
Ranking
n/a
PE Ratio
n/a
Stock Price
38.70
ChartMarket Cap Chart
Since February 29, 2024, Nextage Therapeutics's market cap has increased from 12.50M to 13.04M, an increase of 4.32%. That is a compound annual growth rate of 1.70%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 2, 2026 | 13.04M | -45.12% |
| Dec 31, 2024 | 23.76M | 90.07% |
| Feb 29, 2024 | 12.50M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 126.54B |
| Danel (Adir Yeoshua) | 2.55B |
| Amal Holdings A.D. | 2.30B |
| BrainsWay | 1.73B |
| Evogene | 21.70M |
| Erika Carmel-Tech | 19.58M |
| XTL Biopharmaceuticals | 18.68M |
| Purple Biotech | 18.65M |